BusinessSienna Biopharmaceuticals Establishes Corporate Advisory BoardBy Nasdaq OMXDec 12, 2017, 2:05 PM UTC
BusinessSienna Biopharmaceuticals Announces First Patient Dosed in Phase 2b Trial of Topical SNA-120By Nasdaq OMXOct 24, 2017, 1:05 PM UTC
